The cardiac myocyte is a terminally differentiated cell. In response to increased myocardial workload or damage, myocytes undergo hypertrophic (as opposed to hyperplastic) growth. This response includes transient upregulation of immediate early genes such as c-jun [ 1, 2] . Expression of c-jun is partly controlled by cJun/ATF2 dimers bound to AP-1-like sites in the c-jun promoter [3, 4] . Phosphorylation of c-Jun and ATM by stress-activated protein kinases (SAPKs) increases their transactivating activities [5-81. The hypertrophic response in vivo can be simulated in myocytes cultured from neonatal rat heart ventricles exposed to agonists such as the a-adrenergic agonist phenylephrine (PE) or the vasoconstrictor peptide endothelin-1 (ET-1) [2] , which activate the extracellular-regulated kinases (ERKs) and, to a lesser extent, the SAPKs [9-121. We have studied the effects of ET-1 and PE on the induction and phosphorylation of c-Jun and ATFZ in cultured ventricular myocytes using Western blot analysis.
Ventricular myocytes, isolated and cultured by standard methods [11, 12] , were stimulated with ET-1 (0.1 pM) or PE (50 pM). Nuclear extracts were prepared [ 131 and proteins (100 pg) were separated by SDS-PAGE using 10 96 and 8 96 acrylamide gels to study c-Jun and ATF2 respectively. After transfer to nitrocellulose, specific proteins were identified using primary antibodies to c-Jun and ATFZ (Santa Cruz Biotechnology) and horseradish peroxidase-linked secondary antibodies. Bands were detected by the ECL method. Phosphorylated forms of c-Jun and ATF2 were identified as reduced mobility bands.
ET-1 stimulated a small apparent increase in total c-Jun protein over 30 min ( -.rC.
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and remained above control levels over 6 h ( Figs. 1 and 2 ). The second phase was inhibited by cycloheximide ( In comparison with ET-1, the time course was delayed, reaching a maximum at 1.5 -2 h (Fig. 2) . Inhibition of protein kinase C with 10 pM Ro 31-8220 abolished the second phase of c-Jun induction by ET-1 (Fig. 1) and PE.
In addition to increasing total c-Jun immunoreactivity, ET-1 induced the appearance of phosphorylated c-Jun, identified as a reduced mobility band of approximately 46 kDa apparent molecular mass (Figs. 1 and 2 ). Low levels of phosphorylated ATE2 (reduced mobility bands of approximately 76 kDa apparent molecular weight) were also detected (data not shown). PE induced phosphoc-Jun to a lesser degree than ET-1, and had little effect on ATF2 phosphorylation.
In summary, the hypertrophic agents, ET-1 and PE, induced the synthesis and phosphorylation of c-Jun in ventricular myocytes. ET-1 also stimulated the phosphorylation of A m . These changes may be involved in transcriptional upregulation during cardiac hypertrophy.
